In terms of safety monitoring, its wise to periodically check blood pressure, especially in the early phase of use
However, clinical studies have shown no significant differences in the exposure of oral semaglutide when coadministered with omeprazole, suggesting no clinically relevant interaction
The market for nutrition and dietary supplements ostensibly supporting GLP-1 users is projected to more than triple from $4.1 billion in 2025 to $13 billion by 2035, according to research group Future Market Insights Inc
Explore more pricing and genetics guidance in the PlexusDx Education Hub
These medications mimic the hormone glucagon-like peptide-1, which helps regulate blood sugar and appetite
Emerging data supports GLP-1s cardiovascular benefits, outweighing risks for most, but shared decision-making is key